Free Trial

Nutex Health (NASDAQ:NUTX) Stock Rating Lowered by Wall Street Zen

Nutex Health logo with Medical background

Key Points

  • Wall Street Zen downgraded Nutex Health (NASDAQ:NUTX) from a "buy" rating to a "hold" rating in a recent research note.
  • Maxim Group maintains a "buy" rating on Nutex Health with a target price of $205.00, while the stock currently has an average target price of $252.50.
  • Nutex Health shares opened at $97.19 and have experienced significant institutional investment, with notable stakes acquired by several hedge funds in the second quarter.
  • MarketBeat previews top five stocks to own in October.

Wall Street Zen lowered shares of Nutex Health (NASDAQ:NUTX - Free Report) from a buy rating to a hold rating in a research report report published on Saturday.

Separately, Maxim Group set a $205.00 price target on shares of Nutex Health and gave the company a "buy" rating in a research report on Tuesday, August 26th. Two research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $252.50.

Check Out Our Latest Stock Analysis on NUTX

Nutex Health Stock Up 3.3%

Shares of NUTX traded up $2.98 during trading hours on Friday, hitting $92.96. The stock had a trading volume of 103,187 shares, compared to its average volume of 165,805. Nutex Health has a 1-year low of $17.51 and a 1-year high of $184.27. The firm has a market capitalization of $516.86 million, a P/E ratio of 7.82 and a beta of -0.17. The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26. The firm has a 50 day simple moving average of $93.62 and a 200-day simple moving average of $105.64.

Hedge Funds Weigh In On Nutex Health

Several hedge funds have recently modified their holdings of NUTX. Topline Capital Management LLC raised its holdings in shares of Nutex Health by 72.0% in the 2nd quarter. Topline Capital Management LLC now owns 309,131 shares of the company's stock worth $38,484,000 after purchasing an additional 129,418 shares during the period. Marshall Wace LLP raised its holdings in shares of Nutex Health by 333.4% in the 2nd quarter. Marshall Wace LLP now owns 94,548 shares of the company's stock worth $11,770,000 after purchasing an additional 72,734 shares during the period. Divisadero Street Capital Management LP bought a new stake in shares of Nutex Health in the 2nd quarter worth approximately $7,481,000. Geode Capital Management LLC raised its holdings in shares of Nutex Health by 116.8% in the 2nd quarter. Geode Capital Management LLC now owns 78,859 shares of the company's stock worth $9,819,000 after purchasing an additional 42,484 shares during the period. Finally, American Century Companies Inc. raised its holdings in shares of Nutex Health by 73.0% in the 1st quarter. American Century Companies Inc. now owns 74,359 shares of the company's stock worth $3,497,000 after purchasing an additional 31,366 shares during the period. Institutional investors own 5.32% of the company's stock.

Nutex Health Company Profile

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Recommended Stories

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.